EcoR1 Capital
Overview
EcoR1 Capital is a biotech-focused investment advisory firm that invests in public and private biotechnology companies globally.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Morphic | Sep 2018 | Series B | Co-investor |
| ARVION | Nov 2023 | Private Placement | Lead |
| Cellares | Aug 2019 | Series A | Co-investor |
| Eikon Therapeutics | Jan 2022 | Series B | Lead |
| Freenome | Aug 2020 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Adam Schayowitz
Operating Partner
Caroline Stout
Partner
Catherine McWilliams
Director Of Partner Relations
Basheer Zada
Principal
Sarah Spencer
Principal
Scott Platshon
Investor
Maddie Gehrich
Investor Relations Associate
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is EcoR1 Capital based?
EcoR1 Capital is headquartered in San Francisco, California, United States.
When was EcoR1 Capital founded?
EcoR1 Capital was founded in 2012.
How many portfolio companies does EcoR1 Capital have?
EcoR1 Capital has 32 portfolio companies in Caplight's dataset.
What are some companies in EcoR1 Capital's portfolio?
Portfolio companies visible on Caplight include Morphic, ARVION, Cellares, Eikon Therapeutics, Freenome.
What was EcoR1 Capital's most recent investment shown here?
EcoR1 Capital's most recent investment in this portfolio sample was in ARVION in 2023.
What sectors does EcoR1 Capital focus on?
EcoR1 Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does EcoR1 Capital focus on?
EcoR1 Capital typically invests at the Mid stage.
What is EcoR1 Capital's AUM?
EcoR1 Capital's assets under management are estimated between $1.7B and $3.9B.